Hjem › Interstitielle lungesygdomme › Michigan › Ann Arbor
Interstitielle lungesygdomme kliniske forsøg i Ann Arbor, MI
11 studier for Interstitielle lungesygdomme søger deltagere på steder i og omkring Ann Arbor (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
RekruttererFase 3
- University of Michigan, Ann Arbor
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
RekruttererFase 3
- University of Michigan, Ann Arbor
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
RekruttererFase 2/3
- GSK Investigational Site, Ann Arbor
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Rekrutterer
- University of Michigan - Michigan Medicine, Ann Arbor
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
RekruttererFase 2
- Clinical Research Site, Ann Arbor
PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
RekruttererObservationsstudie
- University of Michigan, Ann Arbor
Platform Clinical Study for Conquering Scleroderma
RekruttererFase 2
- University of Michigan, Ann Arbor
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
RekruttererFase 2/3
- University of Michigan, Ann Arbor
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
RekruttererFase 2
- University of Michigan, Ann Arbor
A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
RekruttererFase 2
- Galderma Investigational Site # 8743, Ann Arbor
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
RekruttererObservationsstudie
- University of Michigan, Ann Arbor
Interstitielle lungesygdomme forsøg i andre byer
- New York City, NY18 studier
- Philadelphia, PA16 studier
- Los Angeles, CA14 studier
- Kansas City, KS13 studier
- Durham, NC13 studier
- Charleston, SC13 studier
- Chicago, IL12 studier
- Houston, TX12 studier
- Aurora, CO11 studier
- Phoenix, AZ9 studier
- Salt Lake City, UT9 studier
- Boston, MA9 studier
Andre studier i Ann Arbor
- Prostatakræft27 studier
- Brystkræft26 studier
- Ikke-småcellet lungecancer26 studier
- Kræft (alle typer)25 studier
- Colorektal kræft23 studier
- Lungecancer23 studier
- Hjertesvigt22 studier
- Akut myeloid leukæmi17 studier
- Kardiovaskulær sygdom16 studier
- Bugspytkirtelkræft14 studier
- Melanom12 studier
- Nyrekancer (renocellulært karcinom)12 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.